Clinical Trials Logo

Clinical Trial Summary

To investigate the efficacy of autologous EBV-specific T-cells for the treatment of patients with aggressive EBV positive extranodal NK/T-cell lymphoma


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01948180
Study type Interventional
Source Cell Medica Ltd
Contact
Status Terminated
Phase Phase 2
Start date September 2014
Completion date September 7, 2018

See also
  Status Clinical Trial Phase
Not yet recruiting NCT02878278 - Differences Between Chidamide Taken Daily and Twice a Week in Therapeutic Effect,Pharmacokinetics, Pharmacodynamics and EB Virus Activation Phase 2
Completed NCT01923766 - Cytotoxic T Cells to Prevent Virus Infections Phase 1
Terminated NCT03699904 - Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control Trial Phase 2
Recruiting NCT01011712 - The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
Active, not recruiting NCT04645147 - Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection Phase 1
Terminated NCT02080416 - Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors Phase 0
Completed NCT02213068 - Belatacept 3 Month Post Transplant Conversion Study Phase 4
Recruiting NCT02779439 - Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation Phase 1
Not yet recruiting NCT05677178 - Response Prediction in EBV-HLH Using Metabonomics Analysis
Completed NCT03650231 - Comparison of Technics for Determination of Epstein-Barr Virus Serological Diagnosis
Active, not recruiting NCT01945814 - Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL) Phase 1
Recruiting NCT02007356 - A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® Phase 2
Completed NCT03755440 - PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients. Phase 2
Completed NCT03973723 - Plasma EBV DNA Monitoring in Post-treatment NPC Patients
Completed NCT02318030 - CNTRP POSITIVE Study